Canadian Drug Registration Support for Prescription and Non-Prescription Products

Bringing a drug product to the Canadian market requires more than clinical data. It demands a clear regulatory pathway, a well-structured submission, compliant labelling, and the ability to respond to Health Canada questions without unnecessary delay. Whether you are filing a New Drug Submission, an Abbreviated New Drug Submission, or a Supplemental filing, the quality and completeness of the initial package shapes the pace and outcome of the entire review. MFLRC works with pharmaceutical companies at every stage of the Canadian drug registration process — from initial product classification and pathway assessment through submission preparation, Health Canada correspondence, and post-approval lifecycle management. Our focus is on helping clients build strong, defensible submissions that reflect current regulatory expectations.